China Sanjiang Fine Chemicals Company Limited

China Sanjiang Fine Chemicals Company Limited

CNSJF
China Sanjiang Fine Chemicals Company LimitedUS flagOther OTC
0.16
USD
- -
- -
187.57MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
3.99
3.7
5.05
6.75
8.67
9.35
7.78
7.05
8.08
7.5
11.25
16.92
- -
Basic EPS, GAAP
0.61
0.13
-0.15
0.56
0.67
0.39
0.46
0.95
0.32
-0.26
0.08
0.46
- -
Free Cash Flow per Basic Share
-0.46
-2.11
-1.14
0.98
0.47
0.36
0.77
-0.18
-0.88
-3
-1.11
-0.34
- -
Dividend per Share
0.15
0.19
- -
0.13
0.18
0.22
0.13
0.3
0.35
0.05
- -
- -
- -
Book Value per Share
1.55
1.66
1.48
1.86
2.2
2.3
2.28
0.09
0.09
2.42
2.47
2.87
- -
Tangible Book Value per Share
2.07
2.09
1.72
2.24
2.88
3.01
2.94
3.96
3.86
3.52
3.7
4.2
- -
Basic Weighted Avg Shares
987
984
984
985
1,026
1,026
1,182
1,181
1,176
1,176
1,167
1,158
1,157
Sales/Revenue/Turnover
3,940
3,637
4,966
6,647
8,897
9,586
9,191
8,323
9,499
8,818
13,128
19,586
- -
Operating Margin (%)
13.72
4.63
-0.17
10.79
9.65
6.73
8.26
14.93
4.1
-2.47
0.75
5.15
- -
Depreciation Expense
169
177
443
622
557
549
598
580
511
545
578
1,090
- -
Net Income, GAAP
605
133
-146
553
691
399
549
1,123
381
-308
91
533
- -
Effective Tax Rate (%)
11.81
11.24
- -
13.56
16.23
22.73
12.34
12.78
14.93
- -
- -
2.41
- -
Profit Margin (%)
15.36
3.65
-2.93
8.31
7.76
4.16
5.97
13.49
4.01
-3.49
0.7
2.72
- -
Working Capital
-735
-1,572
-3,092
-3,083
-2,088
-2,372
-1,827
-2,084
-4,022
-5,690
-6,136
-5,966
- -
LT Debt
512
1,897
1,352
1,081
598
- -
10
1,176
1,960
3,289
3,125
2,449
- -
Total Equity
2,467
2,478
2,248
2,729
3,517
3,594
4,056
4,792
4,741
4,326
4,361
4,894
- -
Return on Invested Capital (%)
10.31
2.17
- -
8.67
11.39
7.72
8.77
12.34
3.24
- -
- -
6.39
- -
Return on Capital (%)
17.81
4.04
- -
11.52
17.13
12.4
11.45
20.11
9.16
- -
- -
6.82
- -
Return on Common Equity (%)
44.75
8.41
-9.41
33.57
33.77
17.29
21.75
80.36
370.74
-20.87
3.19
17.19
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
13,128
2024
- -
- -
- -
- -
19,586
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.08
2024
- -
- -
- -
- -
0.46
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Jianhong Han
Full Time Employees
1,430
Sector
Basic Materials
Industry
Chemicals
Address
Pinghai Road Jiaxing People's Republic of China
IPO Date
Dec 8, 2021
Business
China Sanjiang Fine Chemicals Company Limited (CNSJF) is an investment holding company primarily engaged in the manufacture and supply of ethylene oxide, ethylene glycol, polypropylene, surfactants, and related chemical products; it provides processing services for polypropylene, methyl tert-butyl ether, and surfactants, as well as lease, storage, and asset management services. The company produces core components such as ethylene oxide and AEO surfactants for household cleansing agents including liquid detergents, cosmetics, and ointments; additional offerings encompass methyl tert-butyl ether/carbon four, pentene, water reducing agents, liquefied petroleum gas, and industrial gases like oxygen, nitrogen, and argon. Founded in 2003 and headquartered in Jiaxing Port Area, Zhejiang Province, People's Republic of China, with production facilities in Jiaxing and Xiaoshan boasting aggregate annual capacities of approximately 330,000 metric tons for ethylene oxide and 218,000 metric tons for surfactants, it operates principally in the domestic Chinese market with some overseas reach through its vertically integrated production processes. In a significant recent development, the company commenced an equity buyback plan in September 2025, authorized at its annual general meeting on May 30, 2025, to repurchase up to 10% of its issued share capital or 119 million shares to enhance net asset value and earnings per share; this follows positive 2024 financial results with a 10.3% EBITDA margin in the second half despite petrochemical cycle challenges.